49 results
8-K
tmuf9ff9x8tx
19 Aug 22
Departure of Directors or Certain Officers
1:20pm
8-K
EX-10.1
efc7080ki96mvxh188
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
8-K
EX-10.5
y3odk44zgh
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
8-K
EX-10.7
hsjgtv2dhe7thq
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
8-K
EX-99.1
8pqmjm9rr71w
12 Feb 21
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
5:29pm
8-K/A
EX-99.1
uzk4lfouv zy
15 Dec 20
Financial Statements and Exhibits
9:15am
S-8
EX-5.1
58bpbivs7rz77mdxeru5
25 Nov 20
Registration of securities for employees
4:49pm
8-K
EX-10.2
y367 77n6
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm
8-K
EX-10.3
x65xz
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm
8-K
EX-10.1
otjfpgtbqwld7xqo
2 Nov 20
CURE Pharmaceutical Closes $10 Million Financing
4:05pm
8-K
EX-2.1
c8g4nxho9ojpij
5 Oct 20
Entry into a Material Definitive Agreement
8:16am
8-K
EX-10.2
qf1j9bfb
5 Oct 20
Entry into a Material Definitive Agreement
8:16am